文献速递颈动脉与弓上血管

择期颈动脉血运重建患者术前负荷试验阳性时,颈动脉内膜剥脱术较经股颈动脉支架置入或经颈动脉血运重建的长期死亡率更高

Higher long-term mortality in patients with positive preoperative stress test undergoing elective carotid revascularization with carotid endarterectomy compared to transfemoral carotid artery stenting or transcarotid revascularization.
PubMed 文献 · J Vasc Surg · 2025-03-24

基于VQI VISION数据库2016至2020年18,364例择期颈动脉血运重建患者,比较术前负荷试验阳性与阴性者结局。负荷试验阳性者90天再入院率在颈动脉内膜剥脱术、经股颈动脉支架置入和经颈动脉血运重建中均升高,颈动脉内膜剥脱术组院内术后心肌梗死增加,3年死亡率在颈动脉内膜剥脱术组增加28%,而经股颈动脉支架置入或经颈动脉血运重建组未见此差异。

要点

  • 负荷试验阳性者90天再入院率在颈动脉内膜剥脱术(19.6% vs 15.8%)、经股颈动脉支架置入(33.3% vs 18.6%)和经颈动脉血运重建(25% vs 17.5%)中均显著升高。
  • 颈动脉内膜剥脱术组负荷试验阳性者院内术后心肌梗死显著增加(1.7% vs 0.6%;P < .001),经股颈动脉支架置入或经颈动脉血运重建组未见差异。
  • 颈动脉内膜剥脱术组负荷试验阳性者3年死亡率增加28%(校正HR 1.28,95%CI 1.03-1.58;P = .03),经股颈动脉支架置入或经颈动脉血运重建组未见此差异。

核心结论

  • 择期颈动脉血运重建的适当选择无症状患者中,负荷试验阳性可预测部分围术期和长期心血管结局。
  • 鉴于颈动脉内膜剥脱术组随访死亡率高,作者质疑这些患者是否应优先接受最佳药物治疗和/或支架置入。

研究设计与样本

  • VQI VISION数据库2016至2020年择期颈动脉血运重建患者,按术前2年内是否行心脏负荷试验且未后续行冠状动脉介入分组。
  • 共分析18,364例患者,其中颈动脉内膜剥脱术78.8%、经股颈动脉支架置入9.3%、经颈动脉血运重建11.9%。
  • 35.8%患者行术前负荷试验,其中颈动脉内膜剥脱术37.4%、经股颈动脉支架置入27.5%、经颈动脉血运重建31.9%。
  • 亚组分析比较负荷试验阴性(无缺血或心肌梗死证据)与阳性结果者的结局。

主要发现

  • 负荷试验阳性者90天再入院率:颈动脉内膜剥脱术19.6% vs 阴性15.8%(P = .003);经股颈动脉支架置入33.3% vs 18.6%(P < .001);经颈动脉血运重建25% vs 17.5%(P = .04)。
  • 院内术后神经事件或充血性心力衰竭发生率各组均无差异;颈动脉内膜剥脱术组院内术后心肌梗死显著增加(1.7% vs 0.6%;P < .001),经股颈动脉支架置入或经颈动脉血运重建组无差异。
  • 3年随访中,负荷试验阳性较阴性者行冠状动脉旁路移植术/经皮冠状动脉介入治疗的比例更高:颈动脉内膜剥脱术组校正HR 1.87(95%CI 1.42-2.27;P < .0001),经股颈动脉支架置入组校正HR 3.89(95%CI 1.77-8.57;P < .01),经颈动脉血运重建组未见差异。
  • 颈动脉内膜剥脱术组负荷试验阳性较阴性者3年死亡率增加28%(校正HR 1.28,95%CI 1.03-1.58;P = .03),经股颈动脉支架置入或经颈动脉血运重建组未见此差异。
  • 颈动脉内膜剥脱术组负荷试验阴性较未行负荷试验者3年死亡率降低14%(校正HR 0.86,95%CI 0.76-0.98;P = .02),经股颈动脉支架置入或经颈动脉血运重建组类似负荷试验队列中未观察到该死亡差异。

临床怎么用

  • 作者认为,负荷试验阳性可预测择期颈动脉血运重建患者的部分围术期和长期心血管结局。
  • 作者质疑颈动脉内膜剥脱术组负荷试验阳性患者是否应优先接受最佳药物治疗和/或支架置入。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study compared outcomes in patients with and without preoperative stress testing undergoing carotid revascularization including carotid endarterectomy (CEA), transfemoral carotid artery stenting (TF-CAS), and transcarotid revascularization (TCAR). METHODS: Patients in the Vascular Quality Initiative Vascular Implant Surveillance and Interventional Outcomes Network database who underwent elective carotid revascularization from 2016 to 2020 were included. Patients were analyzed by group based on whether they underwent cardiac stress testing within 2 years preceding revascularization without subsequent coronary intervention. Subset analysis was performed comparing outcomes between those with negative and positive results (evidence of ischemia or myocardial infarction [MI]). Outcomes of interest were postoperative MI/neurological events, 90-day readmission rates, and long-term mortality. RESULTS: We analyzed 18,364 patients (78.8% CEA, 9.3% TF-CAS, and 11.9% TCAR). Of these, 35.8% underwent preoperative stress testing (37.4% of CEA patients, 27.5% of TF-CAS patients, and 31.9% of TCAR patients). Although comorbidities were significantly higher among patients undergoing CEA with a preoperative stress test compared with those without stress testing, the overall prevalence of comorbidities was higher among patients undergoing TF-CAS or TCAR, irrespective of preoperative stress test status. Compared with patients with a negative stress test, patients with a positive stress test undergoing any form of carotid revascularization had a significant increase in 90-day readmission rates (CEA 19.6% vs 15.8% [P = .003]; CAS 33.3% vs 18.6% [P < .001]; TCAR 25% vs 17.5% [P = .04]). No group demonstrated a difference in the incidence of in-hospital postoperative neurological events or congestive heart failure, but those undergoing CEA (but not CAS or TCAR) experienced a significant increase in-hospital postoperative MI (1.7% vs 0.6%; P < .001). In 3-year follow-up, those with a positive compared with negative stress test were more likely to undergo coronary artery bypass graft/percutaneous coronary intervention in the CEA (adjusted hazard ratio [HR], 1.87 [95% confidence interval (CI), 1.42-2.27]; P < .0001) and CAS groups (adjusted HR, 3.89 [95% CI, 1.77-8.57]; P < .01), but not the TCAR cohort. Notably, those undergoing CEA with a positive compared with negative stress test, but not CAS or TCAR, exhibited a 28% increase in mortality (adjusted HR, 1.28 [95% CI, 1.03-1.58]; P = .03) at 3 years. Conversely, those patients with a negative stress test compared with no stress test undergoing CEA experienced a 14% decrease in mortality at 3 years (adjusted HR, 0.86 [95% CI, 0.76-0.98]; P = .02); this mortality difference was not observed in similar stress test cohorts undergoing TF-CAS or TCAR. CONCLUSIONS: Our study highlights that a positive stress test in appropriately selected, asymptomatic patients undergoing elective carotid revascularization can predict select perioperative and long-term cardiovascular outcomes. However, given the high follow-up mortality associated with those undergoing CEA for elective carotid revascularization, our findings call into question whether these patients should be offered optimal medical management and/or stenting preferentially.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ding J, Rokosh RS, Rockman CB, et al. Higher long-term mortality in patients with positive preoperative stress test undergoing elective carotid revascularization with carotid endarterectomy compared to transfemoral carotid artery stenting or transcarotid revascularization. J Vasc Surg. 2025. PMID: 40139286. doi:10.1016/j.jvs.2025.03.188

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。